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Previews
An ideal application of miniature proteins is towardGrafting Miniature
DNA binding. DNA binding proteins contain variousDNA Binding Proteins structural elements to interact with DNA, but the most
prevalent include protein  helices [16]. Protein grafting
using the helical aPP scaffold has been exploited in
constructing miniature DNA binding proteins with high
affinity and specificity [1, 2, 9]. Miniature proteins thatMiniature proteins serve as leads for biological and
interact sequence specifically with DNA have potentialmedicinal applications by positioning all amino acids
application toward development of artificial transcrip-necessary for biomolecular recognition on a compact
tion factors for targeted inhibition or activation of geneprotein structure. Protein grafting was recently used
expression [17].to create miniature helical proteins with high DNA
In this issue of Chemistry & Biology, Turner et al.binding affinity and specificity.
exploited the helix-stabilizing apamin in creating a min-
iature DNA binding protein [18]. By grafting the MyoD
Helical protein structures mediate a variety of important basic helix-turn-helix DNA binding element onto the
biomolecular interactions, including protein-protein, apamin scaffold, an apamin/MyoD hybrid (apaMyoD)
protein-DNA, and protein-RNA interactions. The ability was created that bound its target DNA site with high
to design and control helical proteins’ structure pos- affinity by preorganizing the DNA binding helix.
sesses potential for the development of biological tools To initially probe the helical content of the apaMyoD
to probe protein function in vivo and pharmaceutical fusion, circular dichroism (CD) studies were used. As
drugs targeting helical proteins. Designed helical pro- expected, the apamin amino-terminal loop stabilized he-
teins can also feature functions not available in natural lical structure in the carboxy-terminal MyoD DNA bind-
molecules, such as increased DNA binding specificity ing peptide, increasing helical content from 7%, or 4
or DNA cleavage activity. amino acids, in the native MyoD to 27%, or 19 amino
Multiple strategies aimed at designing helical proteins acids, in apaMyoD. In this case, the disulfide bonds
have utilized helix-stabilizing elements that bypass the in amino-terminal loop nucleated helical structure over
energetic penalty required to nucleate the first helical approximately 10 amino acid residues in the DNA bind-
turn in a disordered peptide. In protein grafting or sur- ing helix. Importantly, helical content was diminished
face grafting, helical structures involved in biomolecular under reducing conditions where the disulfide bonds
interactions have been stabilized by positioning amino were disrupted, indicating that disulfide bonds are re-
acids critical for molecular recognition onto small helical quired to preorganize the MyoD helix. The increase in
protein scaffolds [1–3]. For example, the polyproline helical content of apaMyoD was comparable to the pro-
peptide from avian pancreatic polypeptide (aPP) main- tein grafting strategies employing aPP, which stabilized
tains helical content in its carboxy-terminal region via helical content in up to 21 amino acids [2, 5].
hydrophobic interactions with an amino-terminal polyp- To explore the DNA binding ability of the apaMyoD
roline helix [4]. The stable helical motif in aPP has been fusion, CD and fluorescence anisotropy studies were
exploited as a scaffold for creating helical miniature employed. The presence of apamin increased the melt-
proteins [1, 2, 5–8]. In a recent example, the DNA binding ing temperature of the apaMyoD dimer/DNA complex
element of the Q50K engrailed homeodomain protein by 13 compared with the native MyoD dimer, as as-
was grafted onto the solvent-exposed surface of aPP sessed with CD. Fluorescence anisotropy studies indi-
to create a monomeric miniature protein capable of rec- cated that the presence of apamin stabilized the apa-
ognizing target DNA [9]. MyoD dimer/DNA complex by 1.7 kcal•mole1 relative
Protein grafting has been performed also with other to native MyoD. As expected, the increased DNA binding
helical scaffolds, including the GCN4 leucine zipper [10], affinity of apaMyoD was lost under reducing conditions
the F-actin bundling protein villin [11], the Zif268 zinc where disulfide bonds were disrupted.
finger 2 [12], and the bee venom peptide apamin [13, Turner et al. were also interested in probing the selec-
14]. In the case of apamin, helical content is maintained tivity of DNA binding by apaMyoD, or the ability to dis-
in its carboxy-terminal region via a disulfide-stabilized criminate between target site DNA sequence and non-
amino-terminal loop [15]. The S-peptide from RNase A target site DNA sequences. Despite the apparent lack
was grafted onto the helical apamin scaffold to create of selectivity of native MyoD toward binding target site
a helical S-peptide. By incubating the helical S-peptide versus nontarget site DNA (G  0.07 kcal•mole1),
with the carboxy-terminal catalytic domain of RNase A, the apaMyoD chimera demonstrated higher affinity for
enzymatic activity was reconstituted [13]. In a second its consensus site than for a random sequence of DNA
example, the amino-terminus of the rhodanese protein (G  1.42 kcal•mole1). Therefore, apaMyoD not
was grafted onto apamin, and helical rhodanese protein only allowed for high affinity binding to target DNA sites
was analyzed for binding to its cpn60 chaperone pro- in an disulfide-dependent manner, but it also afforded a
tein [14]. In these cases, protein grafting generated heli- specific interaction not seen in the native MyoD protein.
cal peptides for use in probing the role of helices in Although other strategies have been employed to in-
crease DNA target site selectivity in miniature proteins,protein folding and function.
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cloning of the first sets of polyketide synthases (PKS)Don’t Classify Polyketide
from streptomycetes, numerous different “types” of PKSSynthases genes have been identified from a variety of biological
sources, mostly bacteria, fungi, and plants, but recently
also from protists [1–4]. Although investigations re-
vealed that PKSs show some striking similarities to fatty
Polyketide synthases are intensively studied as me- acid synthase, a more or less systematic approach has
tabolite factories generating diverse biologically ac- been taken to classify the different types of systems
tive natural products. Contrary to their current classifi- based on their source or products as well as biochemical
cation as different “types,” there is now a growing or genetic data.
body of evidence illustrating that nature realized lim- Recently, it has become evident that transition states
itless transitional stages during evolution. between differently classified biosynthetic systems ex-
ist. Nature’s ingenuity for producing natural products is
Polyketides are a remarkable class of natural products. obviously not restricted to “classes” of natural product
In addition to an enormous range of functional and struc- biosynthetic systems. For example, the “parallel and
tural diversity, they exhibit a wide range of biological convergent universes of PKS and nonribosomal peptide
activities, applied in the agrochemistry and pharmaceu- synthetases” (NRPS) [5] were only recognized a few
tical industries, which triggered research aimed at a years ago after the first true hybrid PKS/NRPS systems
with translationally fused PKS and NRPS modules weremolecular understanding of their biosynthesis. Since the
